The mutation rate of SMARCA4 in gastric cancer is relatively low, approximately 2% (8).SMARCA4-deficient tumors are typically poorly differentiated or undifferentiated, exhibit highly malignant and invasive characteristics, and show resistance to chemotherapy (4). Here, SMARCA4 is linked to gastric cancer.